Core Insights - Fagron Sterile Services US (FSS) has been awarded a national group purchasing agreement for compounded sterile services with Premier, Inc., effective July 1, 2025, allowing Premier members to access special pricing and terms for outsourced compounded preparations [1][2]. Company Overview - Fagron Sterile Services US is a leading DEA & FDA registered 503B pharmaceutical outsourcing company focused on providing ready-to-administer, cGMP-compliant compounded preparations to healthcare providers [1][5]. - The company aims to enhance patient safety and support supply chain resilience across various critical care areas, including labor and delivery, ophthalmics, and pain management [5]. Industry Context - The agreement with Premier highlights FSS's role in addressing medication shortages and rising costs in the healthcare sector by providing consistent and cost-effective solutions [3]. - Premier, as a technology-driven healthcare improvement company, serves two-thirds of all healthcare providers in the US, facilitating better care and outcomes through integrated data and analytics [4].